The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Presentation information

Oral Presentation

(E) Biopharmaceutics

[28V09-am] 病態モデル

Sun. Mar 28, 2021 9:00 AM - 10:24 AM [Room V09] Oral Presentation 9 (Online)

座長:安井 裕之(京都薬大)、森田 真也(滋賀医科大)

10:00 AM - 10:12 AM

[28V09-am06] Association of CLEC7A polymorphism with response to infliximab treatment in Japanese patients with Crohn's disease

○Kaito Terui1, Takahiro Gondo1, Yuzuno Kitamoto1, Tatsuo Inamine2, Hajime Isomoto3, Kazuhiro Tsukamoto2 (1. Sch. Pharm. Sci., Nagasaki Univ., 2. Grad. Sch. Biomed. Sci., Nagasaki Univ., 3. Fac. Med., Tottori Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password